4.1 Review

The Role of Immunoproteasomes in Tumor-Immune Cell Interactions in Melanoma and Colon Cancer

出版社

SPRINGER BASEL AG
DOI: 10.1007/s00005-022-00644-x

关键词

Immunoproteasome; Colitis-associated cancer; Melanoma; Tumor microenvironment; T cells

资金

  1. Projekt DEAL
  2. FAZIT Stiftung
  3. DRUID-LOEWE
  4. [DGF-VI 562/10-1]

向作者/读者索取更多资源

The participation of proteasomes in vital cellular and metabolic processes that are involved in tumor growth has made them an attractive target for cancer treatment. Immunoproteasomes have been found to play an important role in tumor development, either promoting inflammation and tumor growth or supporting anti-cancer immunity.
The participation of proteasomes in vital cellular and metabolic processes that are involved in tumor growth has made this protease complex an attractive target for cancer treatment. In contrast to ubiquitously available constitutive proteasome, the increased enzymatic activity of immunoproteasome is associated with tumor-infiltrating immune cells, such as antigen-presenting cells and T lymphocytes. In various tumors, an effective anti-tumor immunity is provided through generation of tumor-associated antigens by proteasomes, contributing crucially to cancer eradication by T lymphocytes. The knowledge regarding the role of immunoproteasomes in the communication between tumor cells and infiltrating immune cells is limited. Novel data suggest that the involvement of immunoproteasomes in tumorigenesis is more complex than previously thought. In the intestine, in which diverse signals from commensal bacteria and food can contribute to the onset of chronic inflammation and inflammation-driven cancer, immunoproteasomes exert tumorigenic properties by modulating the expression of pro-inflammatory factors. In contrast, in melanoma and non-small cell lung cancer, the immunoproteasome acts against cancer development by promoting an effective anti-tumor immunity. In this review, we highlight the potential of immunoproteasomes to either contribute to inflammatory signaling and tumor development, or to support anti-cancer immunity. Further, we discuss novel therapeutic options for cancer treatments that are associated with modulating the activity of immunoproteasomes in the tumor microenvironment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据